Sign in

CIK 0001603454

  • Non-accelerated filer
  • Smaller reporting company

Celcuity Inc.

Sign in to watch
Ticker
CELC
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 763-392-0767
Business address
16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
Former names
Celcuity LLC
  1. 4 Open-market sale Director sold 300 shares at $11.11 ($3,334)
  2. 4 Open-market buy Chief Executive Officer bought 260,869 shares at $5.75 ($1,499,997)
  3. 4 Exercise or conversion Director acquired 250 shares (option exercise)
  4. 4 Open-market buy Director bought 5,000 shares at $9.68 ($48,383)
  5. 4 Open-market sale Director sold 300 shares at $9.97 ($2,991)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 5,000 shares at $8.99 ($44,939)
  9. 4 Open-market sale Director sold 100 shares at $10.02 ($1,002)
  10. 4 Open-market sale Director sold 350 shares at an average $10.01 ($3,503)
  11. 4 Open-market sale Director sold 300 shares at $8.95 ($2,685)
  12. 4 Open-market sale Director sold 300 shares at $9.47 ($2,841)
  13. 4 Open-market buy Director bought 754 shares at $5.94 ($4,482)
  14. 4 Open-market sale Director sold 750 shares at $6.24 ($4,683)
  15. 4 Open-market sale Director sold 250 shares at $5.65 ($1,413)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Director acquired 3,273 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 6 of 10 · 187 filings